Advances in technology now enable genetic testing prior to implantation of embryos that may be predisposed to disease such as cystic fibrosis, for example. To hear Dr. Kathryn Go explain this process and other issues:  www.blogtalkradio.com/creatingafamily.

Meet Dr. Go

Kathryn J. Go, Ph.D. joined the Reproductive Science Center in 2006 after serving as the Director of the IVF Laboratory at Pennsylvania Hospital/Pennsylvania Reproductive Associates, Philadelphia, PA for 21 years.  Dr. Go received her Bachelor’s degree in Biology and Doctor of Philosophy in Molecular Biology from the University of Pennsylvania and completed a post- doctoral fellowship in the Department of Physiology and Biochemistry at the Medical College of Pennsylvania.  Board-certified as a high complexity laboratory director, Dr. Go has served two terms on the Executive Council of the Society of Assisted Reproductive Technology (SART) of the American Society of Reproductive Medicine (ASRM), was a member of the Reproductive Biology Resource Committee of SART and the College of American Pathologists, consultant to the ASRM Office of Government Affairs,  Chair of the Reproductive Biology Professional Group of the ASRM, and was on the faculties of the University of Pennsylvania and Thomas Jefferson University.  Dr. Go is currently President of the New England Fertility Society, has an avid interest in the assisted reproductive technologies and the pursuit and implementation of new techniques in the laboratory to improve patient outcomes, and is the author of articles on quality control and clinical findings, as well as reviews on novel research areas in reproductive biology.